PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
New York · 2025-2026 General Assembly

S04587 Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

Direction

Abortion medication abortionAI label

Expands abortion access model confidence 80%

Allows prescribers to request that the prescription label for mifepristone or misoprostol use the name or address of the prescribing health care practice instead of the prescriber's name (and requires patient notification of this), which protects prescriber privacy and thereby facilitates provision.

at the prescriber's request, the prescription label for mifepristone or misoprostol shall include the name or address of the prescribing health care practice instead of the name of the prescriber.

✓ Quote verified word for word in the bill text

Abortion provider clinic regulationAI label

No change to abortion access model confidence 70%

Requires health care prescribers to inform patients if they have requested to use the name or address of the prescribing health care practice instead of their own name on labels for mifepristone or misoprostol.

A health care prescriber shall inform the patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. Governor
  6. Law

Status: Died (session ended)

Last action
2025-03-10: SUBSTITUTED BY A5285
Filed
2025-02-07
Sponsor
Shelley Mayer D + 1 cosponsor (1 D)

Why the model tagged it this way: The bill amends labeling rules specifically for mifepristone and misoprostol (medication abortion drugs) to allow substitution of a practice name/address for the prescriber's (expanding access by protecting prescriber privacy) and adds a patient-notification requirement (neutral on the abortion axis).

Related bills

Hearings and calendar

Sponsors

Text versions

History (3 actions)
DateChamberAction
2025-03-10SSUBSTITUTED BY A5285
2025-03-04SORDERED TO THIRD READING CAL.447
2025-02-07SREFERRED TO RULES